Affinity Asset Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
2022
Q4
$5.05M Sell
2022
Q3
$4.27M Buy
2022
Q2
$3.45M Sell
2022
Q1
$4.76M Buy
2021
Q4
$3.6M Buy
2021
Q3
$2.4M Sell
2021
Q2
$5.32M Buy
2021
Q1
$3.77M Sell
2020
Q4
$5.76M Buy